Answers are grounded in this paper and cite their sources.
BACKGROUND: Postpartum women living with HIV are at heightened risk for genital tract infections (GTIs), which may impact mucosal immunity and HIV transmission. We investigated the prevalence of bacterial vaginosis (BV) and sexually transmitted infections (STIs) and their association with cervicovaginal cytokine profiles in this population. METHODS: A cross-sectional study was conducted among 66 postpartum women on ART in KwaZulu-Natal, South Africa. BV was diagnosed using Nugent scoring and STIs by molecular assays. Participants were stratified into four groups: no infection, BV only, STI only, and BV+STI. Cervicovaginal lavages (CVLs) were analyzed for concentrations of 12 inflammatory, regulatory, adaptive, growth factor, and hematopoietic cytokines RESULTS: STIs were detected in 27% (18/66) of participants and BV in 69% (45/65); 24% (16/66) were co-infected. BV alone was associated with elevated IL-1α (β=1.01; 95% CI: 0.09-1.92; p = 0.005) and suppression IP-10 (β=-1.35; 95% CI: -2.28, -0.42; p = 0.01) and MCP-1 (β=-1.28; 95% CI: -1.98, -0.57; p < 0.001). Co-infection was linked to increased TNF-α (β=1.08; 95% CI: 0.16-2.00; p = 0.05), IL-1β (β=1.05; 95% CI: 0.05-2.06; p = 0.05) and IL-10 (β=1.10; 95% CI: 0.21-1.99; p = 0.05)whereas STI alone showed no significant changes. CONCLUSION: BV and STI co-infections were common and associated with distinct pro-inflammatory cytokine responses, potentially enhancing HIV shedding and transmission risk. The prevalence and inflammatory effects highlight the importance of integrated reproductive health services and postpartum STI screening. Longitudinal studies are needed to confirm causality and explore interventions mitigating co-infection impact on maternal and HIV transmission risk.
No takes yet. Share an insight, caveat, or question.
Govender et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: